Glaukos (FRA:6GJ) Change In Payables And Accrued Expense : €1.1 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Glaukos Change In Payables And Accrued Expense?

Glaukos's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was €6.8 Mil. It means Glaukos's Accounts Payable & Accrued Expense increased by €6.8 Mil from Sep. 2023 to Dec. 2023 .

Glaukos's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was €1.2 Mil. It means Glaukos's Accounts Payable & Accrued Expense increased by €1.2 Mil from Dec. 2022 to Dec. 2023 .

Glaukos Change In Payables And Accrued Expense Historical Data

The historical data trend for Glaukos's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glaukos Change In Payables And Accrued Expense Chart

Glaukos Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.70

-2.21

11.02

6.81

1.20

Glaukos Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-8.65	-0.24	3.16	6.84	-

Glaukos Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.1 Mil.

Glaukos Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Glaukos's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Glaukos (FRA:6GJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Glaukos Corp (FRA:6GJ) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

GKOS:USA

Address

One Glaukos Way, Aliso Viejo, CA, USA, 92656

Website

https://www.glaukos.com

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Glaukos (FRA:6GJ) Headlines

No Headlines